Detalles de la búsqueda
1.
Lower risks of cirrhosis and hepatocellular carcinoma with GLP-1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework.
J Intern Med
; 295(3): 357-368, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994187
2.
Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study.
Cardiovasc Diabetol
; 22(1): 272, 2023 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37794465
3.
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data.
Diabetes Res Clin Pract
; 198: 110625, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36924833
4.
The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
Front Immunol
; 12: 719650, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413862
Resultados
1 -
4
de 4
1
Próxima >
>>